Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Guy

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The New England Journal of Medicine|June 5, 2018
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaArnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
Urologic Oncology|June 20, 2015
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic featuresRomain Mathieu, Géraldine Pignot, Alexandre Ingles, et al.
BJU International|January 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15)Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The New England Journal of Medicine|June 5, 2018
Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell CarcinomaArnaud Méjean, Alain Ravaud, Simon Thezenas, et al.
Urologic Oncology|June 20, 2015
Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic featuresRomain Mathieu, Géraldine Pignot, Alexandre Ingles, et al.
BJU International|January 17, 2023
Machine-learning approach for prediction of pT3a upstaging and outcomes of localized renal cell carcinoma (UroCCR-15)Astrid Boulenger de Hauteclocque, Loïc Ferrer, Damien Ambrosetti, et al.
European Urology|April 11, 2009
Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgeryKarim Bensalah, Allan J Pantuck, Nathalie Rioux-Leclercq, et al.
European Urology|March 8, 2011
Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general populationYann Neuzillet, Xavier Tillou, Romain Mathieu, et al.
Pageof 9